Subjective assessment of taste and smell disfunction in patients with COVID-19 in Paraguay

Subjective assessment of taste and smell disfunction in patients with COVID-19 in Paraguay

Main Article Content

Carlos Mena Canata
Enrique Pérez Girala
Ta Ju Liu
Raúl Tornaco Maidana
Rodrigo González Insfrán

Abstract

The alteration of the senses of taste and smell in relation to COVID-19 is a widely known phenomenon; however, this alteration has not been exhaustively characterized in the international literature. The following study is proposed with the aim of describing the alterations in the senses of taste and smell in relation to COVID-19 by means of their subjective evaluation.  The nature of the study is observational, descriptive and cross-sectional, and was applied to patients who sought medical attention via remote consultations carried out on virtual platforms of the Service of Otorhinolaryngology and Head and Neck Surgery of the Clínicas Hospital, San Lorenzo, between the months of March and October of 2021. We included 440 patients aged 31.3 ± 9.9 years (18 to 60 years), 308 (70%) female, 388 (88%) from urban areas, with evidence of infection by SARS-CoV-2 by RT-PCR in 260 (59%), predominantly without comorbidities 232 (53%), with fever as the most frequently reported symptom 352 (80%), treated more frequently with NSAIDs 208 (47%) and/or Paracetamol 216 (49%). Both taste and smell alterations in patients who have had COVID-19 have been shown to appear more frequently 1 to 7 days after the onset of symptoms (207 for smell, 184 for taste), occurring more frequently with a total decrease of both senses (anosmia 302 and ageusia 216), recovering completely in most cases (214 and 216) and within a period of 1 to 4 weeks (140 and 130).

References

Carlos Alfonso Romero-Gameros, 1SF-NEA 2020, 'Alteraciones del gusto y olfato en elcontexto de la pandemia por SARSCoV-2. Análisis preliminar', An Orl Mex.

CyC, SEDOY 2021, 'Las alteraciones del gusto y el olfato por COVID-19', Pandemia de COVID.

Gane S.B., KC,HC 2020, 'Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?', Rhinology.

Herrera, C., Betancourt Cervantes, J., Lage Dávila, A. ., Barreto Fiu , E., Sánchez Valdés , L., Chávez González, E., & Caballero López , A. (2021). Título: Variables asociadas a la severidad en pacientes con COVID-19. International Journal of Medical and Surgical Sciences, 8(3), 1–15. https://doi.org/10.32457/ijmss.v8i3.1612

Hopkins C, SPKN 2020, ' Presentation of new onset anosmia during the COVID-19 pandemic', Rhinology.

J. Barón-Sánchez, ACSGG-SMRAARF 2021, 'Afectación del sentido del olfato y el gusto en la enfermedad leve por coronavirus (COVID-19) en pacientes españoles', Elsevier public health collection.

J. Barón-Sánchez, ACSGG-SMRAARF 2021, 'Afectación del sentido del olfato y el gusto en la enfermedad leve por coronavirus (COVID-19) en pacientes españoles', Elsevier Public Health Emergency colection.

Kaye R, CDKKBJDIJ 2020, 'COVID-19 Anosmia Reporting Tool: Initial Findings', Otolaryngol Head Neck Surg..

Lechien J.R., C-ECM,PS,LYV,CP,MQ 2020, 'Clinical and epidemiological characteristics of 1,420 european patients with mild-to-moderate coronavirus disease 2019.', J Intern Med.

Lechien J.R., CP,C-ECM,KM,HS,C-HC 2020, 'Objective olfactory evaluation of self-reported los of smell in a case series of 86 COVID-19 patients. ', Head and neck.

Lechien JR, C-ECDSDEA 2020, 'Olfactory and gustatory dysfunctionsas a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.', Eur Arch Otorhinolaryngol.

Moein ST, HSMBK-TATPDR 2020, 'Smell dysfunction: a biomarker for COVID-19.', Int Forum Allergy Rhinol..

Vaira L.A., HC,SG 2020, 'Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.', Head and neck.

Yan CH, FFPDOBDAS-ROL 2020, 'Self-reported olfactory loss associates with outpatient clinical course in Covid-19.', Int Forum Allergy Rhinol.

Yan CH, FFPDOBDA 2020, 'Self-reported olfactory loss associates with outpatient clinical course in Covid-19.', Int Forum Allergy Rhinol.